相关实验视频

Updated: Jun 7, 2025

Development of Recombinant Proteins to Treat Chronic Pain

Development of Recombinant Proteins to Treat Chronic Pain

Published on: April 11, 2018

螺旋融合的印林-奎纳林杂交物作为对抗TNF-α介导炎症的智能炸弹

Mahmoud S Elkotamy¹, Mohamed K Elgohary¹, Mahmoud Abdelrahman Alkabbani²

¹Pharmaceutical Chemistry Department, Faculty of Pharmacy, Egyptian-Russian University, Badr City, Cairo 11829, Egypt.

International journal of biological macromolecules

|November 16, 2024

概括

新型螺旋融合的印林-奎纳林混合体通过抑制瘤缩因子-α (TNF-α) 显示出强大的抗炎作用. 四种化合物显示出有前途的治疗潜力,具有良好的安全性.

科学领域:

药用化学医学化学
药理学药理学是指药理学的学科.
免疫学免疫学免疫学

背景情况:

炎症是许多疾病的关键因素,需要开发新的抗炎药物.
一种螺旋胺类同类药物显示出中度瘤亡因子-α (TNF-α) 抑制,为进一步调查提供了基础.

研究的目的:

合成和评估新型螺旋融合的印丁-奎纳林杂交物作为潜在的抗炎药物.
通过N-化和化,通过修改异素支架来增强抗炎活性.

主要方法:

螺旋结合的印丁 - 基纳林杂交物 (4a - p) 的合成.
在体内进行针对TNF-α的抗炎试验.
疼痛缓解作用的体外评估,PGE2的抑制,NF-κB和TNFR2-TNF-α的结合.
药物相似性,药物动力学和分子相互作用的in-silico分析.
安全评估,包括组织病理学和器官功能测试.

主要成果:

所有合成的类似物都表现出对TNF-α in-vivo的抗炎活性.
化合物4b,4e,4k和4n被确定为主要候选物.
化合物证明了TNFR2-TNF-α结合的纳米分子抑制.
安全评估表明,化合物具有有利的概况.

结论:

新型螺旋融合的印林-奎纳林混合物代表了一类有前途的抗炎药物.
已确定的化合物 (4b,4e,4k,4n) 需要进一步研究治疗应用.
这些化合物显示出管理炎症疾病的潜力,与现有疗法相比,提高了安全性.

关键词:

抗炎药物抗炎药物抗炎药物印度氨酸 (Indoline) 是一种印度氨酸.分子建模分子建模基纳氨酸是什么?这就是TNF-α.

更多相关视频

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Published on: February 9, 2021

Facilitating Drug Discovery: An Automated High-content Inflammation Assay in Zebrafish

Facilitating Drug Discovery: An Automated High-content Inflammation Assay in Zebrafish

Published on: July 16, 2012

相关概念视频

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

T Cell Types and Functions

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...

Gene Regulation in Microbial Communities: Quorum Sensing

Gene Regulation in Microbial Communities: Quorum Sensing

Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...